BR112017000303A2 - métodos para o tratamento de hipotensão - Google Patents
métodos para o tratamento de hipotensãoInfo
- Publication number
- BR112017000303A2 BR112017000303A2 BR112017000303A BR112017000303A BR112017000303A2 BR 112017000303 A2 BR112017000303 A2 BR 112017000303A2 BR 112017000303 A BR112017000303 A BR 112017000303A BR 112017000303 A BR112017000303 A BR 112017000303A BR 112017000303 A2 BR112017000303 A2 BR 112017000303A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- treating hypotension
- hypotension
- treating
- relates
- Prior art date
Links
- 208000001953 Hypotension Diseases 0.000 title abstract 3
- 230000036543 hypotension Effects 0.000 title abstract 3
- 102000005862 Angiotensin II Human genes 0.000 abstract 1
- 101800000733 Angiotensin-2 Proteins 0.000 abstract 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
- 229950006323 angiotensin ii Drugs 0.000 abstract 1
- 150000003943 catecholamines Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462022054P | 2014-07-08 | 2014-07-08 | |
| PCT/US2015/039499 WO2016007589A1 (en) | 2014-07-08 | 2015-07-08 | Methods for treating hypotension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017000303A2 true BR112017000303A2 (pt) | 2017-11-07 |
Family
ID=55064810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017000303A BR112017000303A2 (pt) | 2014-07-08 | 2015-07-08 | métodos para o tratamento de hipotensão |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20160074465A1 (https=) |
| EP (2) | EP3007722A4 (https=) |
| JP (2) | JP2017519799A (https=) |
| KR (1) | KR20170026486A (https=) |
| CN (1) | CN106794224A (https=) |
| AU (2) | AU2015287955A1 (https=) |
| BR (1) | BR112017000303A2 (https=) |
| CA (1) | CA2954016A1 (https=) |
| EA (2) | EA202091873A3 (https=) |
| IL (1) | IL249936A0 (https=) |
| MX (1) | MX2017000306A (https=) |
| SG (2) | SG10201804034QA (https=) |
| TW (3) | TWI754225B (https=) |
| WO (1) | WO2016007589A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9572856B2 (en) | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
| PL2986308T3 (pl) | 2013-12-18 | 2020-05-18 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Angiotensyna ii w połączeniu do leczenia niedociśnienia |
| US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| PL3400000T3 (pl) | 2016-01-07 | 2024-04-22 | La Jolla Pharma, Llc | Sposoby podawania angiotensyny ii |
| WO2018191678A1 (en) * | 2017-04-14 | 2018-10-18 | La Jolla Pharmaceutical Company | Methods for administering angiotensin ii |
| WO2019118874A1 (en) * | 2017-12-15 | 2019-06-20 | La Jolla Pharma, Llc | Angiotensin compositions and methods related thereto |
| WO2019183416A1 (en) | 2018-03-23 | 2019-09-26 | Nevakar Inc. | Epinephrine compositions and containers |
| KR102258546B1 (ko) | 2018-10-26 | 2021-06-01 | 양성심 | 유기농 케일을 주 성분으로 하는 건강기능식품 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| US20070072817A1 (en) * | 2005-09-29 | 2007-03-29 | Fibrogen, Inc. | Methods for reducing blood pressure |
| RU2011126338A (ru) * | 2008-11-28 | 2013-01-10 | Эбботт Лэборетриз | Стабильные композиции антител и способы их стабилизации |
| US9572856B2 (en) * | 2009-12-16 | 2017-02-21 | The George Washington University a Congressionally Chartered Not-for-Profit Corporation | Method of treating low blood pressure |
| PL2986308T3 (pl) * | 2013-12-18 | 2020-05-18 | The George Washington University, A Congressionally Chartered Not-For-Profit Corporation | Angiotensyna ii w połączeniu do leczenia niedociśnienia |
-
2015
- 2015-07-08 WO PCT/US2015/039499 patent/WO2016007589A1/en not_active Ceased
- 2015-07-08 TW TW109105582A patent/TWI754225B/zh active
- 2015-07-08 TW TW110149288A patent/TW202214219A/zh unknown
- 2015-07-08 JP JP2017500389A patent/JP2017519799A/ja active Pending
- 2015-07-08 KR KR1020177001649A patent/KR20170026486A/ko not_active Ceased
- 2015-07-08 EA EA202091873A patent/EA202091873A3/ru unknown
- 2015-07-08 US US14/794,102 patent/US20160074465A1/en not_active Abandoned
- 2015-07-08 BR BR112017000303A patent/BR112017000303A2/pt not_active Application Discontinuation
- 2015-07-08 CN CN201580048068.XA patent/CN106794224A/zh active Pending
- 2015-07-08 CA CA2954016A patent/CA2954016A1/en not_active Abandoned
- 2015-07-08 SG SG10201804034QA patent/SG10201804034QA/en unknown
- 2015-07-08 SG SG11201610897VA patent/SG11201610897VA/en unknown
- 2015-07-08 MX MX2017000306A patent/MX2017000306A/es unknown
- 2015-07-08 EP EP15775357.5A patent/EP3007722A4/en not_active Ceased
- 2015-07-08 AU AU2015287955A patent/AU2015287955A1/en not_active Abandoned
- 2015-07-08 EP EP18158219.8A patent/EP3381465A1/en not_active Withdrawn
- 2015-07-08 TW TW104122255A patent/TWI688385B/zh active
- 2015-07-08 EA EA201692534A patent/EA036514B1/ru unknown
-
2017
- 2017-01-05 IL IL249936A patent/IL249936A0/en unknown
-
2018
- 2018-06-22 US US16/016,088 patent/US20180311306A1/en not_active Abandoned
-
2020
- 2020-04-17 US US16/851,695 patent/US20200237853A1/en not_active Abandoned
- 2020-05-27 JP JP2020092321A patent/JP2020143139A/ja active Pending
-
2021
- 2021-03-17 AU AU2021201669A patent/AU2021201669A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN106794224A (zh) | 2017-05-31 |
| CA2954016A1 (en) | 2016-01-14 |
| MX2017000306A (es) | 2017-07-10 |
| WO2016007589A1 (en) | 2016-01-14 |
| TW202214219A (zh) | 2022-04-16 |
| AU2021201669A1 (en) | 2021-04-08 |
| IL249936A0 (en) | 2017-03-30 |
| SG10201804034QA (en) | 2018-07-30 |
| JP2017519799A (ja) | 2017-07-20 |
| EP3007722A1 (en) | 2016-04-20 |
| AU2015287955A1 (en) | 2017-02-02 |
| JP2020143139A (ja) | 2020-09-10 |
| TW202038927A (zh) | 2020-11-01 |
| EP3007722A4 (en) | 2016-05-25 |
| TWI754225B (zh) | 2022-02-01 |
| TW201625231A (zh) | 2016-07-16 |
| EA202091873A3 (ru) | 2021-01-29 |
| US20160074465A1 (en) | 2016-03-17 |
| TWI688385B (zh) | 2020-03-21 |
| EA202091873A2 (ru) | 2020-11-30 |
| EP3381465A1 (en) | 2018-10-03 |
| EA036514B1 (ru) | 2020-11-18 |
| US20180311306A1 (en) | 2018-11-01 |
| KR20170026486A (ko) | 2017-03-08 |
| EA201692534A1 (ru) | 2017-06-30 |
| US20200237853A1 (en) | 2020-07-30 |
| SG11201610897VA (en) | 2017-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284172A (en) | Diagnostic methods for t cell therapy | |
| IL255261A0 (en) | Methods for treating cancer | |
| EP3463464A4 (en) | ASSOCIATION TREATMENT | |
| BR112017000303A2 (pt) | métodos para o tratamento de hipotensão | |
| PT3283527T (pt) | Terapêutica de combinação para o cancro | |
| BR112019006160A2 (pt) | composições e métodos para o tratamento das condições oftálmicas | |
| BR112019007613A2 (pt) | terapia de combinação para inibição de c3 | |
| BR112017008399A2 (pt) | abordagem de imunoterapia de combinação para tratamento de câncer | |
| PT3377516T (pt) | Composição para o tratamento do cancro | |
| HRP20190194T1 (hr) | 17a,21-diesteri korteksolona, namijenjeni liječenju tumora | |
| IL254779A0 (en) | Methods of administering glutaminase inhibitors | |
| BR112016017112A2 (pt) | Composições de apilimod e métodos de uso das mesmas | |
| LT3371165T (lt) | Btk inhibitorius, naudojamas vėžiui gydyti | |
| BR112018000776A2 (pt) | métodos para tratamento de câncer usando apilimod | |
| KR20180084772A (ko) | 암 치료를 위한 조합 치료법 | |
| HUE038541T2 (hu) | Rák kezelési módszerek | |
| BR112017008799A2 (pt) | composições de apilimod e métodos de uso das mesmas no tratamento de câncer renal | |
| DK4119569T3 (da) | Konjugerede antisense-forbindelser til anvendelse i behandling | |
| IL249250B (en) | Novel combinations for antigen based therapy | |
| EA201790312A1 (ru) | Комбинации лекарственных средств для лечения множественной миеломы | |
| HUE059448T2 (hu) | Liposzómás készítmény, rák kezelésében való alkalmazásra | |
| DK3296485T3 (da) | Ståldrager | |
| PT3134119T (pt) | Tratamento do cancro | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| BR112017001384A2 (pt) | composto para uso em tratamento anti-helmíntico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |